Alzheimer’s
Novartis and Amgen halt trials into Alzheimer’s drug after patients get worse
July 12, 2019Medical Communications Alzheimer's, Amgen, Banner Alzheimer's Institute, Novartis, dementia, pharma, research
Novartis, Amgen and Banner Alzheimer’s Institute have dropped a study into investigational Alzheimer’s drug CNP520 (umibecestat) after some patient’s conditions …
Pfizer supressed research suggesting arthritis drug Enbrel reduced risk of Alzheimer’s by 64%
June 6, 2019Research and Development Alzheimer's, Drug therapy, Pfizer, dementia, pharma
Pfizer supressed data suggesting that their drug Enbrel reduced the risk of patients developing Alzheimer’s disease by 64%. In 2015, …
Scientists identify new form of dementia
May 1, 2019Research and Development AD, Alzheimer's, dementia, late, neuroscience
A team of scientists from Britain and the United States have described a new form of dementia, according to a …
Google accused of profiting from misleading dementia supplement ads
March 26, 2019Manufacturing and Production Alzheimer's, dementia, google, pseudomedicine, search engines, tech
Google has been accused of profiting from false hope after running adverts for unproven dementia treatments which can cost as …
Biogen and Eisai discontinue Phase 3 Alzheimer’s trial
March 21, 2019Research and Development Alzheimer's, Biogen, CNS, Eisai, mental health
Biogen and Eisai have announced their decision to discontinue a Phase 3 trial looking into the efficacy and safety of …
Antiepileptics increase the risk of pneumonia in people with Alzheimer’s disease
March 21, 2019Research and Development Alzheimer's, R&D, adverse events, antiepileptic drugs, epilepsy, pneumonia
Antiepileptic drugs increase the risk of pneumonia in people living with Alzheimer’s disease, according to research from the University of …
FDA to crack down on dietary supplements
February 12, 2019Manufacturing and Production Alzheimer's, Alzheimers, Cancer, Dietary Supplements, FDA, USA, diabetes
The FDA is cracking down on those selling ‘dietary supplements’, having sent warning letters to companies who claim, without proof, …
Roche pulls plug on Alzheimer’s drug after Phase 3 failure
January 30, 2019Research and Development AC Immune, Alzheimer's, Roche, crenezumab, pharma
Roche has announced that it is to terminate two Phase 3 studies investigating the efficacy of its anti-beta-amyloid molecule crenezumab …
People in England will be able to pay the NHS to sequence their genetic data, if they share it with scientists
January 28, 2019Sales and Marketing Alzheimer's, Cancer, England, NHS, genetic data, genomes, health
The NHS will provide paid-for health reports, informing patients as to the likelihood that they will develop diseases such as …
UK Dementia partnership offering £100,000-200,000 awards for dementia research projects
October 23, 2018Manufacturing and Production Alzheimer's, dementia, development, research
The Dementia Discovery Fund (DDF) in partnership with the UK Dementia Research Institute (UK DRI) has announced that it will …
Tech firm Tencent aims for 3-minute Alzheimer’s diagnosis with new partnership
October 8, 2018Research and Development, Sales and Marketing Alzheimer's, pharma, tencent
Chinese tech firm Tencent has partnered up with London-based healthcare technology firm Medopad in a big to accelerate the diagnosis …
A goal in mind: Transforming the way Alzheimer’s disease is diagnosed and treated
September 20, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Roche, pharma
Dr Rachelle Doody, Global Head of Neurodegeneration at Roche/Genentech, discusses key learnings from clinical trials in Alzheimer’s disease, and how …
The September 2018 issue of Pharmafocus is available to read online now!
September 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, AstraZeneca, Cancer, Iraw, J&J, JJ, Pfizer, Roche, UK, brexit, drug safety, pharma, pharmacovigilance
The new September edition of Pharmafocus is now live and available to read online. We’re entering the final stretch as …
Bill Gates commits $30m towards Alzheimer’s diagnostic test
July 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Bill Gates, billionaire, diagnosis
Microsoft business magnate Bill Gates has joined a coalition of philanthropists in committing more than $30 million towards the development …
Another failure in Alzheimer’s creates bleak outlook for treatment
June 12, 2018Manufacturing and Production, Research and Development Alzheimer's, AstraZeneca, Eli Lilly, biotech, drugs, pharma, pharmaceutical
Finding a treatment for Alzheimer’s disease has been one of the aims of big pharma for last few decades, but …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
